GW572016, a novel dual EGFR/Her-2 small molecule, tyrosine kinase inhibitor induces regression and significant growth delay in tamoxifen-resistant, MCF-7 derived tumors.
Publication
, Conference
Blackwell, K; Spector, N; Snyder, S; Marks, J; Broadwater, LH; McDonnell, D; Dewhirst, M; Xia, W; Liu, LH
Published in: BREAST CANCER RESEARCH AND TREATMENT
December 1, 2002
Duke Scholars
Published In
BREAST CANCER RESEARCH AND TREATMENT
ISSN
0167-6806
Publication Date
December 1, 2002
Volume
76
Start / End Page
S130 / S130
Location
SAN ANTONIO, TEXAS
Publisher
KLUWER ACADEMIC PUBL
Conference Name
25th San Antonio Breast Cancer Symposium
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Blackwell, K., Spector, N., Snyder, S., Marks, J., Broadwater, L. H., McDonnell, D., … Liu, L. H. (2002). GW572016, a novel dual EGFR/Her-2 small molecule, tyrosine kinase inhibitor induces regression and significant growth delay in tamoxifen-resistant, MCF-7 derived tumors. In BREAST CANCER RESEARCH AND TREATMENT (Vol. 76, pp. S130–S130). SAN ANTONIO, TEXAS: KLUWER ACADEMIC PUBL.
Blackwell, K., N. Spector, S. Snyder, J. Marks, L. H. Broadwater, D. McDonnell, M. Dewhirst, W. Xia, and L. H. Liu. “GW572016, a novel dual EGFR/Her-2 small molecule, tyrosine kinase inhibitor induces regression and significant growth delay in tamoxifen-resistant, MCF-7 derived tumors.” In BREAST CANCER RESEARCH AND TREATMENT, 76:S130–S130. KLUWER ACADEMIC PUBL, 2002.
Blackwell K, Spector N, Snyder S, Marks J, Broadwater LH, McDonnell D, et al. GW572016, a novel dual EGFR/Her-2 small molecule, tyrosine kinase inhibitor induces regression and significant growth delay in tamoxifen-resistant, MCF-7 derived tumors. In: BREAST CANCER RESEARCH AND TREATMENT. KLUWER ACADEMIC PUBL; 2002. p. S130–S130.
Blackwell, K., et al. “GW572016, a novel dual EGFR/Her-2 small molecule, tyrosine kinase inhibitor induces regression and significant growth delay in tamoxifen-resistant, MCF-7 derived tumors.” BREAST CANCER RESEARCH AND TREATMENT, vol. 76, KLUWER ACADEMIC PUBL, 2002, pp. S130–S130.
Blackwell K, Spector N, Snyder S, Marks J, Broadwater LH, McDonnell D, Dewhirst M, Xia W, Liu LH. GW572016, a novel dual EGFR/Her-2 small molecule, tyrosine kinase inhibitor induces regression and significant growth delay in tamoxifen-resistant, MCF-7 derived tumors. BREAST CANCER RESEARCH AND TREATMENT. KLUWER ACADEMIC PUBL; 2002. p. S130–S130.
Published In
BREAST CANCER RESEARCH AND TREATMENT
ISSN
0167-6806
Publication Date
December 1, 2002
Volume
76
Start / End Page
S130 / S130
Location
SAN ANTONIO, TEXAS
Publisher
KLUWER ACADEMIC PUBL
Conference Name
25th San Antonio Breast Cancer Symposium
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences